Small molecule discovery offers hope for treatment of Angelman syndrome

FHS
July 8, 2024
12:39 pm

Angelman syndrome is a rare genetic disorder caused by mutations in the maternally-inherited UBE3A gene and characterized by poor muscle control, limited speech, epilepsy, and intellectual disabilities.

Ginkgo to cut at least 35% of staff in multi-year restructuring plan

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 26, 2024

Review: Facilitators and barriers to vaccination uptake in pregnancy

Researchers from St George’s, University of London have identified key barriers to vaccine uptake for whooping cough, flu and Covid-19 in pregnant women, and outline

April 23, 2024

AI could revolutionize sudden cardiac death prediction and prevention

Predicting sudden cardiac death, and perhaps even addressing a person’s risk to prevent future death, may be possible through artificial intelligence (AI) and could offer

November 6, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.